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Fraxinus rhynchophylla Hance (Oleaceae), its stem barks are known as Cortex fraxini (秦皮 qín pí) listed in
Chinese Pharmacopoeia. Phytochemical study has indicated that methanol extracts from Qinpi has
protective effect on acute liver injury. The present study investigates the hepatoprotective activity of
EtOHewater extract from the seeds of F. rhynchophylla Hance against carbon tetrachloride-induced liver
injury in mice. The EtOHewater extract signiﬁcantly alleviated liver damage as indicated by the
decreased levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), the
malondialdehyde (MDA) content, and increased the levels of superoxide dismutase (SOD), glutathione
(GSH) and glutathione peroxidase (GSH-Px), and reduced the pathological tissue injury induced by CCl4.
Quantitative analysis of seven major constituents (1e7) in EtOHewater extract (EWE) was developed by
high performance liquid chromatography-diode-array detector (HPLC-DAD). The current research in-
dicates that the EWE from the seeds of F. rhynchophylla Hance decreased liver index, inhibited the in-
crease of serum aminotransferase induced by CCl4, and decreased hepatic MDA content, SOD and GSH-Px
activities. These results suggested that the pretreatment with EWE protected mice against CCl4-induced
liver injuries. Based on the results, the EtOHewater extract from the seeds of F. rhynchophylla Hance is
efﬁcacious for prevention and treatment of CCl4-induced hepatic injury in mice. Secoiridoid and tyrosol
glucosides might be the active ingredients responsible for the biological and pharmacological activities of
hepatoprotection.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The liver plays an important role in human metabolism and
detoxiﬁcation of endogenous and exogenous chemicals.1 Liver in-
juries or dysfunctions have been recognized as serious health
problem. Especially acute and chronic liver injuries resulted from
the exposure to toxic chemicals, drugs, and virus inﬁltration from
ingestion or infection, have gained more attention in recent
years.2e4 Corticosteroids and interferon has been used for the
treatment of hepatic diseases, however, these synthetic chemicalx: þ86 29 88302223.
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).
al., Hepatoprotective standa
ntary Medicine (2016), http:drugs are not well accepted by patients due to limited therapeutic
efﬁcacy and serious complications.5 Therefore, more effective
complementary and therapeutic drugs with low or no side-effects
are needed for the treatment of liver diseases.6e9 In recent years,
some effective and safe dietary ingredients for liver-protection have
been isolated from traditional medicinal plants, such as glycyr-
rhizin,10 curcumin,11 resveratrol,12 as well as silybin and sily-
marin.13,14 Fraxinus rhynchophylla Hance (Oleaceae) is a commonly
used Chinese traditional medicinal plant, mainly distributed in
China and Korea.15 Its stem bark also known as Cortex fraxini (Qinpi)
is Chinese herbal drug for treating diseases such as acute
conjunctivitis and psoriasis; arresting discharges; curing chronic
bronchitis; and bacillary dysentery, diuretic, antirheumatic, anal-
gesic, antiperspiratory effects, and enhancing eyesight.16 Phyto-
chemical study has indicated that methanol extracts fromQinpi has
protective effect on acute liver injury.17 Many natural products suchrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
rdized EtOHewater extract from the seeds of Fraxinus rhynchophylla
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coumarinolignans have been identiﬁed from this plant.18e23
Recently, several pharmacological activities of phytochemical con-
stituents isolated from the barks and leaves of F. rhynchophylla have
been carried out, including anti-diabetes effects,24e28 anti-Toxo-
plasma gondii effects,29 including antioxidant enzymes,30 inhibiting
amyloid-b-induced neuronal cell damage,31 and inhibiting nitric
oxide synthesis activities.32 Hydrangeside B, along with other
secoiridoid glucosides showed hepatoprotective activities against
DL-galactosamine-induced toxicity in human hepatocyte HL-7702
(HL-7702) cells.33 Secoiridoid glycoside, oleuropein, showed anti-
hepatitis B virus (HBV) activity and effectively blocked hepatitis B
surface antigen (HBsAg) secretion with an IC50 of 23.2 mg/mL in
HepG2.2.15 cells with no signiﬁcant cytotoxicity.34 The hep-
atoprotective activity of oleuropein against carbon tetrachloride
(CCl4)-induced liver damage in mice was achieved through the NF-
E2-related factor 2-mediated induction of heme oxygenase-1.35
Recently, Peng et al.36 investigated the effect of Fraxinus rhyncho-
phylla ethanol extract (FREtOH) on liver ﬁbrosis induced by CCl4 in
rats. However, the hepatoprotective activity of the seeds of F.
rhynchophylla Hance has not been evaluated so far.
The present study aimed to evaluate the hepatoprotective ac-
tivity of EtOHewater extract from the seeds of F. rhynchophylla
Hance employing a widely used CCl4-induced liver damage model
in mice and quantitative analysis of six secoiridoid glucosides (1e6)
and one tyrosol glucoside (7) by high performance liquid chroma-
tography-diode-array detector (HPLC-DAD) method.2. Materials and methods
2.1. Chemicals and reagents
CH3OH (HPLC grade), CH3CH2OH (HPLC grade), and CH3CN
(HPLC grade) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). All other organic solvents used in the current study, such as
CH3OH, ethyl acetate (EtOAc), acetone, and chloroform (CHCl3)
were of analytical grade. They are commercially available from
Hengxing Chemical Reagent Co., Ltd. (Tianjin, China). Chemical
standards of oleoside dimethyl ester (1), ligstroside (2), nuzhenide
(3), 10-hydroxoleoside dimethyl ester (4), GI3 (5), GI5 (6), and sal-
idroside (7) were prepared in our laboratory. The purity of each
compound was >98%, determined by HPLC analysis. The chemical
structures of these reference compounds are shown in Fig. 1.Fig. 1. Structures of c
Please cite this article in press as: Guo S, et al., Hepatoprotective standa
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The seeds of F. rhynchophylla Hance were provided in August
2013 from Baoji City, Shaanxi province, China. The herbariums of
F. rhynchophylla Hance (FRH001) were deposited in Room 612,
Department of Pharmaceutical Engineering, College of Chemical
Engineering, Northwest University.
2.3. HPLC analysis conditions
HPLC analysis was performed on an Agilent 1260 separation
module connected to a G1315D DAD detector using a Synergi 4u
Hydro-RP 80R column (250 4.6 mm, 4 mm,100 Å) with a ﬂow rate
of 1.0 mL/min. Solvent system: 0 min: 95% A (1% phosphoric acid)
and 5% B (acetonitrile), 2 min: 95% A (1% phosphoric acid) and 5% B
(acetonitrile), 5 min: 80% A (1% phosphoric acid) and 20% B
(acetonitrile), 25 min: 75% A (1% phosphoric acid) and 25% B
(acetonitrile), 27 min: 95% A (1% phosphoric acid) and 5% B
(acetonitrile), 30 min: 95% A (1% phosphoric acid) and 5% B
(acetonitrile). At the end of the run, 100% of acetonitrile was
allowed to ﬂush the column for 10 min, and an additional 10 min of
post run time was set to allow for equilibration of the columnwith
the starting eluant. The UV detector was operating at 230 nm, and
the column temperature was maintained at 30 C.
2.4. Calibration curves
Methanol stock solutions containing the seven standard com-
pounds 1e7 were prepared and diluted to ﬁve different ﬁnal con-
centrations. A calibration curve was constructed for each of the
compounds by plotting peak areas versus compound
concentrations.
2.5. Preparation of seeds of F. rhynchophylla Hance extract
The 5 kg air-dried seeds of F. rhynchophylla Hance were perco-
lated twice with absolute ethyl alcohol at room temperature. The
ethyl alcohol was evaporated under vacuum. The herb residue was
then percolated twice with water at room temperature and made
the SFR-water extracts. Finally, mixed the above two extracts, and
the in vivo bioactivity study of seeds of F. rhynchophylla Hance was
carried on by this sample. The HPLC spectrum of the extract is
shown in Fig. 2.ompounds 1e7.
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Fig. 2. The HPLC chromatogram of EtOHeWater extract.
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2.6.1. Animals
Male Kunming mice (weighing 18e22 g), obtained from the
Experimental Animal Center of Xi'an Jiaotong University, were
used. The animal ethical approval communication number is SCXK
2012-003 (Northwest University, Xi'an, Shaanxi, China). All animals
were grouped and housed in polyacrylic cages (29  18  16 cm)
with no more than six animals per cage and maintained under
standard laboratory conditions (temperature 25 ± 2 C, relative
humidity 50 ± 10%) with dark and light cycle (14/10 h). The mice
were acclimatized to laboratory condition for 5 days before
commencement of experiment. All the experiments were per-
formed in accordance with the Regulations of Experimental Animal
Administration issued by the State Committee of Science and
Technology of People's Republic of China.2.6.2. CCl4-induced hepatotoxicity model
Mice were randomly divided into ﬁve groups of 12 animals
each. In the control group (group I) and CCl4-intoxicated group
(group II), mice were given a single daily dose of distilled water
(0.2 mL/10 g, intragastrically (ig)). In the test groups, mice were
given 2.0 g (group IV) and 4.0 g (group V) of EtOHewater extract
(EWE) per kg body weight (BW) once daily. In group III, silymarin
was served as a positive control, and mice were given 0.1 g/kg
BW. All administrations were conducted for 7 weeks. On the 49th
day, all mice except those in the control group were given
simultaneously a CCl4/peanut oil mixture (0.1:100, intraperito-
neally, 0.1 mL/10 g, ig) 2 h after the last administration, while the
control group received peanut oil alone. Then all the animals
were fasted for 16 h and were subsequently tested for the
following analysis.2.6.3. Liver index
Liver index was determined as percent of wet liver weight to
body weight.Please cite this article in press as: Guo S, et al., Hepatoprotective standa
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After blood collection, serumwas separated by centrifugation at
604 g at room temperature for 20 min. The serum alanine amino-
transferase (ALT) and aspartate aminotransferase (AST) values were
measured with commercially available diagnostic kits produced by
Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
2.6.5. Determination of MDA, SOD and GSH-Px activity
After the animals were sacriﬁced, livers were immediately
excised. With the exception of a portion of the left lobe to be used
for histopathological examination, the livers were homogenized in
phosphate buffer (50 mM, pH 7.4) and centrifuged at 420 g for
20 min at 4 C. The malondialdehyde (MDA) content, superoxide
dismutase (SOD) and glutathione peroxidase (GSH-Px) activities
along with protein levels in the supernatant were measured ac-
cording to commercially available diagnostic kits.
2.6.6. Histopathological examinations
A left lobe portion of the liver was incubated for 24 h in 10%
neutral formalin solution. Based on standard procedures, we ob-
tained 5 mm sections for histopathological studies using hematox-
ylin and eosin (H&E) staining.
2.6.7. Statistical analysis
The datawere analyzed in triplicate, using SAS software, version
8.1 (SAS Institute, Cary, NC, USA). Tukey's test was used to deter-
mine statistical significance. The values were considered signiﬁ-
cantly different when the P-value was lower than 0.05.
3. Results
3.1. HPLC method validation
All calibration curves made by the HPLC method exhibited
excellent linear regressions with the determination coefﬁcients (r2)
ranging from 0.99 to 0.9999, and the calibration ranges adequately
covered variations (Table 1).rdized EtOHewater extract from the seeds of Fraxinus rhynchophylla
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Table 1
Calibration curves and LOD and LOQ data of 7 compounds investigated by HPLC.
No. Calibration curvesa r2 Linear range (mg/mL) LODb (mg/mL) LOQb (mg/mL)
1 Y ¼ 26.3302 þ 15081.4372X 0.9998 0.02e0.48 0.0005 0.0016
2 Y ¼ 40.3439 þ 13692.4304X 0.9986 0.01e0.24 0.0048 0.0158
3 Y ¼ 667.3964 þ 4408.5855X 0.9999 0.07e3.50 0.0012 0.0035
4 Y ¼ 1578.7230 þ 15651.8470X 0.9993 0.10e1.20 0.0330 0.0992
5 Y ¼ 481.0792 þ 6299.1942X 0.9984 0.20e3.20 0.0010 0.0034
6 Y ¼ 2.0423 þ 1721.8740X 0.9999 0.05e1.20 0.0038 0.0119
7 Y ¼ 1228.5054 þ 2292.3870X 0.9999 0.20e2.40 0.0250 0.0840
a Y is the value of peak area, and X is the value of the reference compound's concentration (mg/mL).
b LOD and LOQ were determined at S/N of about 3 and 10, respectively.
Fig. 3. Effects of EWE on liver index. Different lower case letters correspond to sig-
niﬁcant differences at P < 0.05. Group I was the control group. Group II was CCl4-
treated group. Group III was given CCl4 þ silymarin. Group IV and V were given
CCl4 þ 2.0 and 4.0 g/kg BW of EWE respectively.
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According to these results, the content of compound 3
(377.280 mg/g) was higher than other compounds, and the content
of compound 5 was 330.960 mg/g in EtOHewater extract from the
seed of F. rhynchophylla Hance (Table 2). The content of total ana-
lytes is 778.086 mg/g or 77.81% in EtOHewater extract from the
seed of F. rhynchophylla Hance.
3.3. The hepatoprotective activities assays
3.3.1. EtOHewater extract (EWE) decreased liver index
Liver swelling induced by CCl4 wasmanifested on the increase of
liver index. As shown in Fig. 3, in the model group (CCl4-intoxicated
group), liver index was 4.96, which was signiﬁcantly higher than
control group (P < 0.05). Pretreatment with EWE signiﬁcantly
decreased liver index compared with model group (P < 0.05).
3.3.2. EWE inhibited the increase of serum aminotransferase
induced by CCl4
The results of hepatoprotective effect of EWE on the serum ALT
and AST activities are shown in Fig. 4. In CCl4-intoxicated group,
serum ALT and AST activities were 239.46 and 11.97 U/L, respec-
tively, whereas the values of control group were only 46.79 and
2.34 U/L, respectively. Therefore, a signiﬁcant increase in the ac-
tivities of serum ALT and AST was observed when liver was
exposured to CCl4 (P < 0.05). Administrationwith different doses of
EWE for 49 days signiﬁcantly reduced the activities of serum ALT
and AST as compared to the control group (P < 0.05) in a dose-
dependent manner. Silymarin, which has been used as medicine
for liver disease, had superior effects on decreasing serum ALT and
AST activities.
3.3.3. EWE decreased hepatic MDA content, SOD and GSH-Px
activities
The levels of MDA, SOD and GSH-Px are indicators of oxidative
stress. A 30.77% increase of MDA content was observed in model
group compared with control group (Fig. 5). Pretreatment with
EWE and silymarin could completely inhibit CCl4-induced increase
of liver MDA content. As shown in Figs. 6 and 7, hepatic SOD and
GSH-Px activities were decreased by 44.21% and 59.96%,Table 2
Contents of seven compounds in the EtOHewater extract of seeds of F. rhynchophylla Ha
No Contents of analytesa (mg/g, n ¼ 3)
1 2 3 4
EtOHewater 2.247 2.930 377.280 11.244
a Content ¼ X
V1 ðinjection volume of standard solutionÞ
V2 ðinjection volume of sample solutionÞ
 V ðsample volumeÞ
M ðsample amountÞ
b Extraction rate ¼ solids content of the extract/sample volume.
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EWE signiﬁcantly increased SOD and GSH-Px activities (P < 0.05).3.4. Histopatholgy
The histological observations of the hepatoprotective effects of
EWE on CCl4-induced liver damage are illustrated in Fig. 8. Liver
sections from control mice displayed regular cellular morphology
(Fig. 8A). Compared with the normal liver tissues of control mice,
liver tissue in CCl4-intoxicated mice revealed liver injury charac-
terized by dilated sinusoidal spaces, and inﬂammatory cell inﬁl-
tration (Fig. 8B). However, the hepatic lesions induced by treatment
with CCl4 were remarkably ameliorated in hypertrophy of hepa-
tocytes, dilated sinusoidal spaces and inﬂammatory cell inﬁltration
by treatment with silymarin and different dose of EWE (Fig. 8CeE).nce.
Extraction rate (w %)b
5 6 7
330.960 27.368 26.057 9.08
rdized EtOHewater extract from the seeds of Fraxinus rhynchophylla
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Fig. 4. Effects of EWE on serum ALT and AST. Different lower case letters correspond to
signiﬁcant differences at P < 0.05. Group I was the control group. Group II was CCl4-
treated group. Group III was given CCl4 þ silymarin. Group IV and V were given
CCl4 þ 2.0 and 4.0 g/kg BW of EWE respectively.
Fig. 6. Effects of EWE on hepatic SOD activity. Different lower case letters correspond
to signiﬁcant differences at P < 0.05. Group I was the control group. Group II was CCl4-
treated group. Group III was given CCl4 þ silymarin. Group IV and V were given
CCl4 þ 2.0 and 4.0 g/kg BW of EWE respectively.
S. Guo et al. / Journal of Traditional and Complementary Medicine xxx (2016) 1e7 54. Discussion
The therapeutic beneﬁts of Chinese herbal medicine have been
recognized for centuries on the basis of clinical experience and
practice. Qinpi, the stem barks of F. rhynchophylla Hance, is a
traditional Chinese herbal drug for treating various types of chronic
diseases.
ALT and AST are aminotransferases and associated with liver
parenchymal cell. The enzymes normally present in the cytosol and
are leaked out into the blood stream, when the hepatocellular
plasma membrane is damaged. Thus, ALT and AST serum levels are
very sensitive markers employed in the diagnosis of liver diseases.
Rats administered once with CCl4 exhibited liver injury, as indi-
cated by signiﬁcant elevation in serum markers for hepatic cellFig. 5. Effects of EWE on hepatic MDA. Different lower case letters correspond to
signiﬁcant differences at P < 0.05. Group I was the control group. Group II was CCl4-
treated group. Group III was given CCl4 þ silymarin. Group IV and V were given
CCl4 þ 2.0 and 4.0 g/kg BW of EWE respectively.
Please cite this article in press as: Guo S, et al., Hepatoprotective standa
Hance, Journal of Traditional and Complementary Medicine (2016), http:damage (ALT and AST).37 At present study, in EWE-treated groups
(2.0 and 4.0 g/kg) of rats, the studies showed that treatment with
EWE signiﬁcantly and dose-dependently decreased the elevations
of serum levels of ALT and AST. Furthermore, the improvement of
the hepatic impairment was achieved and could be observed by
EWE intervention in CCl4-induced liver injury. Thus, the results
showed the protective effects of EWE on hepatic pathology and
orally administered EWE exerted therapeutic effects on CCl4-
induced liver injury in rats.
Oxidative stress associated with lipid peroxidation is involved in
liver development. The extracts and the identiﬁed compounds from
F. rhynchophylla Hance had been reported anti-oxidative
activity.30e32 MDA is an aldehyde, which is a product of poly-
unsaturated fatty acid peroxidation, and is a highly toxic molecule
considered as more than just a marker of lipid peroxidation. In thisFig. 7. Effects of EWE on hepatic GSH-Px activity. Different lower case letters corre-
spond to signiﬁcant differences at P < 0.05. Group I was the control group. Group II was
CCl4-treated group. Group III was given CCl4 þ silymarin. Group IV and V were given
CCl4 þ 2.0 and 4.0 g/kg BW of EWE respectively.
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Fig. 8. Effects of EWE on hepatic morphological analysis (200 H&E): control mice (A), CCl4-treated mice (B), mice pretreated with silymarin prior to CCl4 (C), mice pretreated with
2.0 (D) and 4.0 g/kg (E) BW of EWE respectively prior to CCl4. (➝ dilated sinusoidal spaces, ⇨ inﬂammatory cell inﬁltration).
S. Guo et al. / Journal of Traditional and Complementary Medicine xxx (2016) 1e76study, the elevated hepatic MDA level was decreased by pretreat-
ment of EWE, so it indicated that EWE could protect the liver
against CCl4-induced lipid peroxidation. GSH and SOD are a host of
antioxidant systems to protect the hepatocyte from oxidative
stress. GSH, or GSH-Px, and SOD work in concert to control the
cascades of uncontrolled lipid peroxidation and protect cell from
oxidative damage by scavenging of reactive oxygen species (ROS) or
the toxic free radicals.38e40 In this study, the CCl4-model rats pre-
sent lower GSH-Px and SOD level than the control group. Thus, it
was supposed that EWE possessed the properties to enhance GSH-
Px and SOD, and could prevent hepatice impairment via inhibiting
oxygen-free radicals and increasing anti-oxidation in CCl4-induced
liver injury in rats.
5. Conclusion
In conclusions, the current research indicates that the EtOHe-
water extract (EWE) from the seeds of F. rhynchophylla Hance
decreased liver index, inhibited the increase of serum amino-
transferase induced by CCl4, and decreased hepatic MDA content,
SOD and GSH-Px activities. These results suggested that the pre-
treatment with EWE protected mice against CCl4-induced liver
injuries. Further hepatoprotective effect and the possible mecha-
nism of active constituents of the seeds of F. rhynchophylla Hance
will be studied.
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